Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 27 papers were listed this time. Here's a handful in our areas of our research interest:
Yang KY, Caughey AB, Little SE, et al. A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families. Fam Cancer. 2011 May 3. [Epub ahead of print] PubMed PMID: 21538078.
Gillespie P, O'Shea E, Murphy AW, et al; for the SPHERE study team. Relative cost effectiveness of the SPHERE intervention in selected patient subgroups with existing coronary heart disease. Eur J Health Econ. 2011 May 3. [Epub ahead of print] PubMed PMID: 21537952.
Soini EJ, Martikainen JA, Nousiainen T. Treatment of follicular non-Hodgkin's lymphoma with or without rituximab: cost-effectiveness and value of information based on a 5-year follow-up. Ann Oncol. 2011 May;22(5):1189-97. PMID: 21135053
Nagy B, Brennan A, Brandtmüller A, Thomas SK, Sullivan SD, Akehurst R. Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models. Int J Geriatr Psychiatry. 2011 May;26(5):483-94. PMID: 20845395.
